Evidence map›Paper›PMID 34031483›Full record

ArticleScientific reports2021

COVID-19 diagnosis by routine blood tests using machine learning.

Matjaž Kukar, Gregor Gunčar, Tomaž Vovko, Simon Podnar, Peter Černelč, Miran Brvar, Mateja Zalaznik, Mateja Notar, Sašo Moškon, Marko Notar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Predicting the severity of COVID-19 using machine learning methods.BMC medical informatics and decision making · 2026
    Article
  6. Article
  7. Neuromorphic chips for biomedical engineering.Mechanobiology in medicine · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Matjaž Kukar *Smart Blood Analytics Swiss SA, Höschgasse 25, 8008, Zurich, Switzerland.
Gregor Gunčar *Smart Blood Analytics Swiss SA, Höschgasse 25, 8008, Zurich, Switzerland.
Tomaž VovkoDepartment of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Simon PodnarDivision of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Peter ČernelčDivision of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Miran BrvarCentre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Mateja ZalaznikDepartment of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Mateja NotarSmart Blood Analytics Swiss SA, Höschgasse 25, 8008, Zurich, Switzerland.
Sašo MoškonSmart Blood Analytics Swiss SA, Höschgasse 25, 8008, Zurich, Switzerland.
Marko NotarSmart Blood Analytics Swiss SA, Höschgasse 25, 8008, Zurich, Switzerland. marko@sba-swiss.com.
Ljubljana University Medical Centre · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physicians taking care of patients with COVID-19 have described different changes in routine blood parameters. However, these changes hinder them from performing COVID-19 diagnoses. We constructed a machine learning model for COVID-19 diagnosis that was based and cross-validated on the routine blood tests of 5333 patients with various bacterial and viral infections, and 160 COVID-19-positive patients. We selected the operational ROC point at a sensitivity of 81.9% and a specificity of 97.9%. The cross-validated AUC was 0.97. The five most useful routine blood parameters for COVID-19 diagnosis according to the feature importance scoring of the XGBoost algorithm were: MCHC, eosinophil count, albumin, INR, and prothrombin activity percentage. t-SNE visualization showed that the blood parameters of the patients with a severe COVID-19 course are more like the parameters of a bacterial than a viral infection. The reported diagnostic accuracy is at least comparable and probably complementary to RT-PCR and chest CT studies. Patients with fever, cough, myalgia, and other symptoms can now have initial routine blood tests assessed by our diagnostic tool. All patients with a positive COVID-19 prediction would then undergo standard RT-PCR studies to confirm the diagnosis. We believe that our results represent a significant contribution to improvements in COVID-19 diagnosis.

Indexed as

Machine LearningAgedArea Under CurveBiomarkersCOVID-19EosinophilsFemaleHematologic TestsHumansMaleProthrombinROC CurveSARS-CoV-2Sensitivity and SpecificitySerum AlbuminSeverity of Illness IndexBiomarkersProthrombinSerum Albumin

Identifiers

PMID34031483
PMCPMC8144373
OpenAlexW3033612360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.